
Jeanne Marrazzo, who succeeded Anthony Fauci as director of the National Institute of Allergy and Infectious Diseases in 2023, has been dismissed by US health secretary Robert F. Kennedy Jr.
The move came 22 days after she filed a whistleblower complaint with the Office of Special Counsel. Her claims included the cancellation of research grants, halting of clinical trials, and censorship of scientific work.
Dr Marrazzo, an expert on the human microbiome, alleged in her September complaint that leaders at the National Institutes of Health and the Department of Health and Human Services had taken actions that posed “a substantial and specific danger to public health and safety.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze